Drug recall

HemosIL ReadiPlasTin, Part No. 0020301400

FDA recall event 90012 · Class II · Instrumentation Laboratory

Key facts

Event ID 90012
Recall numbers Z-1052-2022
Recalling firm Instrumentation Laboratory
Product type Devices
Products HemosIL ReadiPlasTin, Part No. 0020301400
Classification Class II
Status Ongoing
Voluntary or mandated Firm Initiated
Reason for recall Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically…
Initiation date Apr 8, 2022
Report date May 18, 2022
City Bedford
State MA
Country United States
FEI number 1217183

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls